Skip to main content
NEXTURNBIOSCIENCE Co., LTD logo

NEXTURNBIOSCIENCE Co., LTD — Investor Relations & Filings

Ticker · 089140 ISIN · KR7089140008 KO Professional, scientific and technical activities
Open in API
Filings indexed 486 across all filing types
Latest filing 2021-10-29 Capital/Financing Update
Country KR South Korea
Listing KO 089140

About NEXTURNBIOSCIENCE Co., LTD

http://www.nexturn.co.kr

NEXTURNBIOSCIENCE Co., LTD. is a specialized manufacturer of Computer Numerical Control (CNC) automatic lathes, with a focus on Swiss-type models. The company develops and produces a range of machines, including both guide bush and non-guide bush types, utilizing proprietary technology. In addition to its core machinery business, NEXTURNBIOSCIENCE leverages its expertise in ultra-precision manufacturing to produce essential functional components. These high-quality parts serve critical applications across diverse sectors, including information technology (IT), construction equipment, and the medical industry, reflecting the company's expanding business scope.

Recent filings

Filing Released Lang Actions
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a formal 'Major Matter Report' (주요사항보고서) filed with the Financial Services Commission/Korea Exchange regarding the 'Decision to Issue Convertible Bonds' (전환사채권 발행결정). It details the terms of the bond issuance, including interest rates, maturity, conversion prices, and put options. This falls under the category of capital structure changes and financing activities, which is classified as 'CAP'.
2021-10-29 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership (specifically by Korea Securities Finance Corp in Nexturn Bioscience) and is filed with the Financial Services Commission and the Korea Exchange. This falls under the category of Major Shareholding Notification.
2021-10-12 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea under the Capital Markets Act. This document is used to report significant changes in share ownership (crossing thresholds or changes in purpose). Based on the provided filing categories, this corresponds to a 'Major Shareholding Notification'.
2021-09-27 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in ownership, and collateral agreements (pledges) of a major shareholder (Studio Santa Claus Entertainment) in Nexturn Bioscience. This falls under the category of Major Shareholding Notification (MRQ) as it tracks significant ownership thresholds and changes.
2021-08-25 Korean
반기보고서 (2021.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for Nexturn Bioscience, covering the period from January 1, 2021, to June 30, 2021. It contains detailed financial and operational information, including company history, management changes, capital structure, and production data. As it is a comprehensive financial report for a period shorter than a full fiscal year containing substantive financial data, it is classified as an Interim/Quarterly Report (IR). H1 2021
2021-08-13 Korean
[기재정정]타법인주식및출자증권취득결정
M&A Activity Classification · 100% confidence The document is a regulatory filing from a Korean company (Nexturn Bioscience) regarding the acquisition of shares in another company (NexID Lab). It is a formal disclosure of a corporate action (investment/acquisition) and includes details on the transaction, the target company, and the board's decision. Since it does not fit into specific categories like M&A (which usually implies a merger or takeover of a business entity rather than a simple share acquisition for investment) or other specialized categories, it falls under the general regulatory filing category.
2021-08-06 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.